Alan J. Wilensky

4.3k total citations · 1 hit paper
61 papers, 3.1k citations indexed

About

Alan J. Wilensky is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alan J. Wilensky has authored 61 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Psychiatry and Mental health, 39 papers in Pediatrics, Perinatology and Child Health and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alan J. Wilensky's work include Epilepsy research and treatment (44 papers), Pharmacological Effects and Toxicity Studies (38 papers) and Neuroscience and Neuropharmacology Research (10 papers). Alan J. Wilensky is often cited by papers focused on Epilepsy research and treatment (44 papers), Pharmacological Effects and Toxicity Studies (38 papers) and Neuroscience and Neuropharmacology Research (10 papers). Alan J. Wilensky collaborates with scholars based in United States, France and Australia. Alan J. Wilensky's co-authors include Sureyya Dikmen, L. M. Ojemann, Nancy Temkin, Carl B. Dodrill, René H. Levy, H. Richard Winn, Mark Holmes, Patrick N. Friel, Gail D. Anderson and George A. Ojemann and has published in prestigious journals such as New England Journal of Medicine, Neurology and Annals of Neurology.

In The Last Decade

Alan J. Wilensky

61 papers receiving 3.0k citations

Hit Papers

A Randomized, Double-Blin... 1990 2026 2002 2014 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan J. Wilensky United States 30 2.0k 1.6k 737 699 361 61 3.1k
Howard N. Bockbrader United States 27 983 0.5× 991 0.6× 644 0.9× 507 0.7× 301 0.8× 58 3.5k
Arnold R. Gammaitoni United States 39 1.3k 0.7× 1.1k 0.7× 413 0.6× 564 0.8× 374 1.0× 116 3.8k
Francesco Pisani Italy 32 2.1k 1.1× 1.9k 1.2× 269 0.4× 728 1.0× 428 1.2× 132 3.5k
Henn Kutt United States 32 1.3k 0.7× 1.4k 0.9× 344 0.5× 490 0.7× 85 0.2× 103 3.2k
John A. Messenheimer United States 33 2.5k 1.3× 2.2k 1.4× 179 0.2× 703 1.0× 414 1.1× 87 3.8k
Kenneth W. Sommerville United States 29 1.8k 0.9× 1.1k 0.7× 229 0.3× 618 0.9× 232 0.6× 64 2.8k
A. Richens United Kingdom 41 3.3k 1.7× 3.6k 2.3× 359 0.5× 1.2k 1.8× 383 1.1× 188 6.0k
Fritz E. Dreifuss United States 42 3.7k 1.9× 3.0k 1.9× 265 0.4× 1.3k 1.9× 798 2.2× 96 5.5k
Tapani Keränen Finland 31 1.3k 0.7× 820 0.5× 531 0.7× 705 1.0× 212 0.6× 93 2.6k
R. Eugene Ramsay United States 35 3.9k 2.0× 3.3k 2.1× 567 0.8× 1.7k 2.4× 820 2.3× 102 5.3k

Countries citing papers authored by Alan J. Wilensky

Since Specialization
Citations

This map shows the geographic impact of Alan J. Wilensky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan J. Wilensky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan J. Wilensky more than expected).

Fields of papers citing papers by Alan J. Wilensky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan J. Wilensky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan J. Wilensky. The network helps show where Alan J. Wilensky may publish in the future.

Co-authorship network of co-authors of Alan J. Wilensky

This figure shows the co-authorship network connecting the top 25 collaborators of Alan J. Wilensky. A scholar is included among the top collaborators of Alan J. Wilensky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan J. Wilensky. Alan J. Wilensky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmes, Mark, et al.. (2003). Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes. Seizure. 13(5). 340–345. 61 indexed citations
2.
Holmes, Mark, et al.. (2003). Identifying Potential Surgical Candidates in Patients with Evidence of Bitemporal Epilepsy. Epilepsia. 44(8). 1075–1079. 42 indexed citations
3.
Vossler, David G., et al.. (2002). Serum and CSF Glutamine Levels in Valproate‐related Hyperammonemic Encephalopathy. Epilepsia. 43(2). 154–159. 60 indexed citations
4.
Holmes, Mark, Donald E. Born, Roman L. Kutsy, et al.. (2000). Outcome after surgery in patients with refractory temporal lobe epilepsy and normal MRI. Seizure. 9(6). 407–411. 77 indexed citations
5.
Temkin, Nancy, Sureyya Dikmen, Gail D. Anderson, et al.. (1999). Valproate therapy for prevention of posttraumatic seizures: a randomized trial. Journal of neurosurgery. 91(4). 593–600. 245 indexed citations
6.
Holmes, Mark, Alan J. Wilensky, L. M. Ojemann, & G. A. Ojemann. (1999). Predicting outcome following reoperation for medically intractable epilepsy. Seizure. 8(2). 103–106. 29 indexed citations
7.
Lin, Yi‐Xin, Gail D. Anderson, Eric D. Kantor, L. M. Ojemann, & Alan J. Wilensky. (1999). Differences in the Urinary Excretion of 6‐β‐Hydroxycortisol/Cortisol between Asian and Caucasian Women. The Journal of Clinical Pharmacology. 39(6). 578–582. 50 indexed citations
8.
Anderson, Gail D., et al.. (1997). Therapeutic Monitoring: Revised Winter–Tozer Equation for Normalized Phenytoin Concentrations in Trauma and Elderly Patents with Hypoalbuminemia. Annals of Pharmacotherapy. 31(3). 279–284. 40 indexed citations
9.
Anderson, Gail D., Barry E. Gidal, Eric D. Kantor, & Alan J. Wilensky. (1994). Lorazepam‐Valproate Interaction: Studies in Normal Subjects and Isolated Perfused Rat Liver. Epilepsia. 35(1). 221–225. 32 indexed citations
10.
Kroetz, Deanna L., Bradley M. Kerr, Lynne V. McFarland, et al.. (1993). Measurement of in vivo microsomal epoxide hydrolase activity in white subjects. Clinical Pharmacology & Therapeutics. 53(3). 306–315. 21 indexed citations
11.
Anderson, Gail D., Andrew Acheampong, Alan J. Wilensky, & René H. Levy. (1992). Effect of Valproate Dose on Formation of Hepatotoxic Metabolites. Epilepsia. 33(4). 736–742. 39 indexed citations
12.
Dodrill, Carl B. & Alan J. Wilensky. (1992). Neuropsychological Abilities Before and After 5 Years of Stable Antiepileptic Drug Therapy. Epilepsia. 33(2). 327–334. 70 indexed citations
13.
Ojemann, L. M., et al.. (1992). Long-term treatment with gabapentin for partial epilepsy. Epilepsy Research. 13(2). 159–165. 39 indexed citations
14.
Kerr, Bradley M., Allan E. Rettie, A. Craig Eddy, et al.. (1989). Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: In vitro/in vivo correlation. Clinical Pharmacology & Therapeutics. 46(1). 82–93. 70 indexed citations
15.
Neppe, Vernon M., et al.. (1988). Fundamentals of carbamazepine use in neuropsychiatry.. PubMed. 49 Suppl. 4–6. 12 indexed citations
16.
Wilensky, Alan J., Patrick N. Friel, L. M. Ojemann, H. J. Kupferberg, & René H. Levy. (1985). Pharmacokinetics of W‐554 (ADD 03055) in Epileptic Patients. Epilepsia. 26(6). 602–606. 53 indexed citations
17.
Lévy, R H, et al.. (1983). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 14(1). 75–76. 1 indexed citations
18.
Troupin, Allan S., et al.. (1979). Evaluation of clorazepate (Tranxene®) as an anticonvulsant—a pilot study. Neurology. 29(4). 458–458. 20 indexed citations
19.
Friel, Patrick N., et al.. (1979). Valproic Acid-Phenytoin Interaction. Therapeutic Drug Monitoring. 1(2). 243–248. 16 indexed citations
20.
Lowden, J. A., et al.. (1974). Screening for carriers of Tay-Sachs disease: A community project.. PubMed. 111(3). 229–33. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026